#667: Nattokinase vs. Statins: The Plaque Study You Were Never Told About

Does lower cholesterol equal less plaque? The answer may surprise you. On this episode of Vitality Radio, Jared explores emerging research on nattokinase, a systemic enzyme derived from fermented soybeans, and its potential role in supporting cardiovascular health. He reviews a 2017 clinical trial comparing nattokinase with a commonly prescribed statin, discusses why imaging studies of arterial plaque may offer a different perspective than cholesterol markers alone, and explains how fibrin may influence plaque structure. Jared also breaks down the importance of dosage, why many studies suggest higher amounts may produce different results than standard servings, and how systemic enzymes fit into a broader heart health strategy. As always, he encourages listeners to understand the research, ask better questions, and work with qualified healthcare professionals when making decisions about their cardiovascular health.Products:NattokinaseFibrenza Systemic EnzymesSun Nutrition Vascular Defense Systemic Enzyme & N.O. BlendVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.This podcast is produced by DrTalks.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drtalks.com/podcast-service/